Minovia's MNV-201 has scored US FDA Fast Track and Rare Pediatric Disease designations for treating Pearson Syndrome.
#news #BiotechNews #HealthcareInnovation #FDAApproval #CellTherapy #RareDisease #AntiAgingScience #NasdaqListing #LifeSciences #RarePediatricDisorders #HealthyAging #ClinicalTrials
0
0
0
0